Related references
Note: Only part of the references are listed.Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lopes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients Three-Year Results of a Scandinavian Randomized Trial
Satish Arora et al.
CIRCULATION-HEART FAILURE (2018)
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
J. Michael Gaziano et al.
LANCET (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Early aspirin use and the development of cardiac allograft vasculopathy
Miae Kim et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up
Yael Peled et al.
CLINICAL TRANSPLANTATION (2017)
Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection
A. Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Allograft Vasculopathy The Achilles' Heel of Heart Transplantation
Sharon Chih et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation
Juan F. Delgado et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy
Guillaume Coutance et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report-2015; Focus Theme: Early Graft Failure
Lars H. Lund et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010
Mandeep R. Mehra et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Improving propensity score weighting using machine learning
Brian K. Lee et al.
STATISTICS IN MEDICINE (2010)
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: A 24-month analysis
Mario Vigano et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection
Luciano Potena et al.
TRANSPLANTATION (2006)
The cumulative effect of acute rejection on development of cardiac allograft vasculopathy
SC Stoica et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Cardiac allograft vasculopathy: pathology, prevention and treatment
M Kass et al.
CURRENT OPINION IN CARDIOLOGY (2006)
Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy
MR Mehra
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant atheroma
HA Valantine
TRANSPLANTATION (2003)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Use of rapamycin slows progression of cardiac transplantation vasculopathy
D Mancini et al.
CIRCULATION (2003)
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
JC Fang et al.
LANCET (2002)
Share Paper
